Arcosa, Inc. is 3.4x more valuable than Proto Labs Inc by market capitalization ($6.23 B vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACA | PRLB |
|---|---|---|
| Market cap | $6.23 B | $1.84 B |
| US-listed rank | #1249 | #2164 |
| Revenue (latest FY) | $2.88B | $533.13M |
| Net income (latest FY) | $208.40M | $21.24M |
| Net margin | 7.2% | 4.0% |
| P/E (trailing FY) | 29.9 | 86.5 |
| SEC filings | 632 | 878 |
Arcosa, Inc. is 3.4x more valuable than Proto Labs Inc by market capitalization ($6.23 B vs $1.84 B).
In their latest fiscal years, Arcosa, Inc. reported $2.88B in revenue while Proto Labs Inc reported $533.13M.
Full pages: Arcosa, Inc. and Proto Labs Inc, or browse the full rankings.